Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03494374Not ApplicableRecruiting

The Effect of Orthosis and Exercise in Pes Planus

Role: lead

NCT03677843Recruiting

Multidimensional Approach in Patients With Severe Cerebral Palsy, Prospective Cohort(MAPCP Cohort)-Offline

Role: lead

NCT03680196Not ApplicableCompleted

The Effect of Botulinum Toxin Injection at Hip Adductor Muscles in Patients With Spastic Cerebral Palsy, Pilot Study

Role: lead

NCT03675984Not ApplicableCompleted

Development of Exercise Protocol for Scoliosis Using Surface Electromyography(S-EMG)

Role: lead

NCT02180880Phase 4Completed

Symptom Based Treatment of Neuropathic Pain

Role: lead

All 5 trials loaded